Cite
HARVARD Citation
Rutherford-Parker, N. et al. (2020). Voxelotor Treatment Interferes With Quantitative and Qualitative Hemoglobin Variant Analysis in Multiple Sickle Cell Disease Genotypes. American journal of clinical pathology. 154 (5), pp. 627-634. [Online].